GlassScriptPhysician profile
Danielle D Bartley
NPI 1790083251
$11,012.13
in general payments reported to CMS, 2019-2025
12 companies · $3,689 in 2025
The $3,689 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,204 · 2022: $1,157 · 2023: $788 · 2024: $4,175 · 2025: $3,689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,250 · Food and Beverage: $2,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,250.00 |
| Food and Beverage | $2,401.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,616.17 | 2021-2025 | |
| Alkermes, INC. | $519.91 | 2021-2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $462.10 | 2021-2025 | Caplyta |
| Axsome Therapeutics, INC. | $323.92 | 2023-2025 | Auvelity |
| Vanda Pharmaceuticals INC. | $315.48 | 2021-2025 | Fanapt, Hetlioz |
| Lundbeck LLC | $213.35 | 2021-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $189.99 | 2021-2025 | Rexulti, Abilify Maintena |
| E.R. Squibb & Sons, L.L.C. | $172.85 | 2024-2025 | Cobenfy |
| Janssen Pharmaceuticals, INC | $155.04 | 2021-2024 | Spravato, Invega |
| Teva Pharmaceuticals USA, INC. | $20.40 | 2024 | Uzedy |
| Zealand Pharma US, INC. | $11.85 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Bartley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.